Type 1 diabetes trials in Netherlands

In Netherlands 17 Also abroad 539

17 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 3Taking people
A Study of Baricitinib (LY3009104) for the Delay of Stage 3 Type 1 Diabetes in At-Risk Children and Adults
Where
Rotterdam
Age
1 year to 35 years
People
150 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07222137 · EU 2025-521797-34-00
Phase 3Taking people
A Study of Baricitinib (LY3009104) to Preserve Beta Cell Function in Children and Adults Newly Diagnosed With Type 1 Diabetes (BARICADE-PRESERVE)
Where
Rotterdam
Age
1 year to 35 years
People
300 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07222332 · EU 2025-522170-36-00
Phase 3Taking people
A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes
Where
Amersfoort, Leiden, Rotterdam
Age
1 year to 25 years
People
723 worldwide
Run by
Sanofi
See details and how to joinNCT07088068
Phase 3Taking people
A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight
Where
Arnhem, Born, Hoofddorp, Hoogeveen, Rotterdam, 's-Gravenhage, 's-Hertogenbosch
Age
18 years and over
People
2,500 worldwide
Run by
Novo Nordisk A/S
See details and how to joinNCT07564414 · EU 2025-522488-14-00
No phaseTaking people
Clinical Evaluation of the Medtronic Implantable Insulin Pump System (MIIPS 2020) in Adult Subjects With Type 1 Diabetes (CIP347)
Where
Zwolle
Age
18 years and over
People
40 worldwide
Run by
Medtronic MiniMed, Inc.
See details and how to joinNCT06739811
Phase 2Taking people
METabolic MODulation to Enhance Insulin Sensitivity and Mitochondrial Function in Type 1 Diabetes (MetMod-T1D)
Where
Amsterdam
Age
18 years to 69 years
People
60 worldwide
Run by
University of Washington
See details and how to joinNCT07699380
Phase 1Taking people
A Phase 1 study of a novel sublingual insulin formulation
Where
Enschede
Age
18 years to 64 years
People
19
Run by
Sublin B.V.
See details and how to join2025-521863-11-00 · EU 2025-521863-11-00
Phase 1Taking people
A Study Investigating the Safety, Absorption, Elimination, and the Effect on the Immune System of ACI-19764 in Healthy Participants and in Participants With Cardiovascular Risk Factors
Where
Groningen
Age
18 years to 75 years
People
114
Run by
AC Immune SA
See details and how to joinNCT07463196 · EU 2025-523885-25-00
No phaseTaking people
Making Diabetes Care Fit for Young Adults Living With Type 1 Diabetes: Observations, Reflections and Expert Opinions
Where
Leiden, Rotterdam
Age
18 years to 30 years
People
60
Run by
Leiden University Medical Center
See details and how to joinNCT07498738
Phase 3Taking people
A Safety, Tolerability, and Efficacy Study of VX-880 and VX-017 in Participants With Type 1 Diabetes
Where
Leiden
Age
18 years to 65 years
People
57 worldwide
Run by
Vertex Pharmaceuticals Incorporated
See details and how to joinNCT04786262 · EU 2024-513929-23-00
Phase 4Taking people
Anti-inflammatory drug to prevent complications in type 1 diabetes
Where
Nijmegen
Age
18 years and over
People
80
Run by
Radboud universitair medisch centrum Stichting
See details and how to join2025-521397-34-00 · EU 2025-521397-34-00
No phaseTaking people
Effect of 4 Weeks of Oral Probiotic Desulfovibrio Piger Supplementation on Immunological and Metabolic Parameters in Individuals With Longstanding Type 1 Diabetes
Where
Amsterdam
Age
18 years and over
People
20
Run by
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
See details and how to joinNCT07585994
No phaseNot yet taking people in Netherlands
Evaluation of the Safety and Effectiveness of the Novel Medtronic Experimental Automated Insulin Delivery System (NMX8) in Adults Living With Type 1 Diabetes
Where
Almelo, Amsterdam, Maastricht
Age
18 years and over
People
230 worldwide
Run by
Medtronic MiniMed, Inc.
See details and how to joinNCT07401901
Phase 1/2Taking people
Tolerogenic dendritic cell therapy in type 1 diabetes; a phase 1b safety and immunological effecitivity study
Where
Leiden, Rotterdam
Age
18 years to 64 years
People
10
Run by
Academisch Ziekenhuis Leiden
See details and how to join2023-508558-25-01 · EU 2023-508558-25-01
No phaseTaking people
EXtremely Early-onset Type 1 Diabetes EXtremely Early-onset Type 1 Diabetes (A Musketeers' Memorandum Study)
Where
Leiden
Age
Up to 70 years
People
300 worldwide
Run by
University of Exeter
See details and how to joinNCT03369821
Phase 2Taking people
Faecal Autologous Capsule Transplantation for Type 1 Diabetes Mellitus
Where
Amsterdam
Age
18 years to 45 years
People
110
Run by
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
See details and how to joinNCT07083882
No phaseTaking people
Effect of Inulin Supplementation on Glycaemic Control and Immunological Parameters in Type 1 Diabetes (2024)
Where
Amsterdam
Age
18 years to 70 years
People
76
Run by
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
See details and how to joinNCT07050888